9 August 2021
Researchers with the VA Bedford and VA Boston health care systems have developed a non-invasive optical technique to help detect Alzheimer’s disease. The new technique uses spectroscopy – measuring how light is scattered and absorbed when passing through matter – to identify structural changes in the brain. This scanning method could become a simple, completely non-invasive method of early Alzheimer’s detection, according to the researchers, and also has potential as a way to assess the effectiveness of treatment.
5 August 2021
The COVID-19 pandemic has significantly altered the delivery of health care including neuropsychological evaluations. Telehealth procedures may become a standard feature in healthcare after the crisis has resolved. In a mini-forum published JAD experts describe how neuropsychological tests that combine digital technology with standard paper and pencil tests can reveal behavioral information not otherwise obtainable and facilitate earlier identification of individuals with emergent neurodegenerative and other neurological illness.
4 August 2021
Obesity is linked to several cardiometabolic abnormalities, such as high blood sugar and hypertension, which are considered to be risk factors for Alzheimer’s disease. In a new study, published in JAD, researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report that obesity alone is not associated with cognitive decline among Latinos.
2 August 2021
This JAD special supplement focuses on the challenges posed by brain disease and presents significant research contributions from Latin America and the Caribbean that address these challenges to help improve the lives of individuals with Alzheimer's disease.
29 July 2021
According to a study published in JAD, people born in winter seem to carry a life-long disadvantage in cognitive ageing. Specifically, their cognitive skills are lower when compared to people born in other seasons, even when taking into account other influencing characteristics, such as their education, depression or cardiovascular diseases.
27 July 2021
Keystone Bio Advances a More Complete Explanation of Porphyromonas Gingivalis Toxic Virulence Factors
Keystone Bio presents a detailed review of the literature show incomplete human and animal model study design(s) for the “local” gingipains AD brain model, but rather using new data and existing publication(s) – support a “peripheral” model of Pg blood-transported toxic virulence factors/OMVs as the major delivery mechanism into the brain. This can now be integrated into a more unifying “concept” and explanation for the “infection hypothesis” for Alzheimer’s disease (AD) and other dementia-related disease(s).
12 July 2021
During neuropsychological assessments, participants complete tasks designed to study memory and thinking. Based on their performance, the participants receive a score that researchers use to evaluate how well specific domains of their cognition are functioning. The study found that the use of a digital pen during cognitive assessments allows researchers to identify patterns of test performance that correlate with different measures of cognitive and physical function.
22 June 2021
The US is one of the only nations in the world that allows pharmaceutical companies to advertise directly to patients: now, TV ads have been linked with higher utilization rates for certain prescription drugs, especially among older patients. This is according to a study published in JAD and authored by Professor Robin Feldman of the University of California Hastings College of Law.
22 June 2021
A new book in the JAD book series Advances in Alzheimer's Disease links elevated air pollution exposure to an increased risk of Alzheimer’s disease and other neurodegenerative disorders, with early signs of disease found even in toddlers and young adults with sustained high exposure.
18 June 2021
Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new study by researchers from The University of Texas Health Science Center at San Antonio and collaborating institutions suggests.